Search
for
Sort by
Research 91–120 of 1000+
- Consequences of Anabolic-Androgenic Steroid Abuse in Males; Sexual and Reproductive Perspective
- Androgens and Antiandrogens
- New Biomarkers to Evaluate Hyperandrogenemic Women and Hypogonadal Men
- P-18 THREE BODY PROBLEM PATIENT: EHLER DANLOS SYNDROME COMBINED WITH HYPOPHOSPHATASIA AND FATTY ACID OXIDATION DEFECT
- Fertility and sexual life of men after their forties and in older age
- Notes from the Editor Emeritus: Medical therapy for hair loss: what we know and what we need to find out
- Гормональный дисбаланс как фактор развития хронического простатита: механизмы и перспективы терапии
- (423) A Case Series of Successful Off-label Use of Flibanserin
- Obstructive Sleep Apnea Due to Endogenous Testosterone Production in a Woman
- 8679 Case: The Sexual, Physical and Psychological Effects of Post-Finasteride Syndrome
- Determinants of Plasma Androgen and Estrogen Levels in Men
- Pharmacological basis for clinical use of antiandrogens
- Cushing's syndrome in the elderly: data from the European Registry on Cushing's syndrome
- Evaluating the safety profile of α-1 blockers, 5α-reductase inhibitors, and PDE5I for BPH: a disproportionality analysis of real-world adverse events based on FDA adverse event reporting system (FAERS)
- 5α-Reductase inhibitor therapy: Should physicians be concerned with persistent diminished libido, erectile dysfunction and depression in a subset of patients?
- Polymorphisms in androgen and estrogen receptor genes: effects on male aging
- Adverse Side Effects of 5α‐Reductase Inhibitors Therapy: Persistent Diminished Libido and Erectile Dysfunction and Depression in a Subset of Patients
- Prostate-Sparing Effects in Primates of the Potent Androgen 7α-Methyl-19-Nortestosterone: A Potential Alternative to Testosterone for Androgen Replacement and Male Contraception1
- Finasteride and Male Breast Cancer: Does the MHRA Report Show a Link?
- Effects of <i>In Utero</i> Exposure to D-004, a Lipid Extract from <i>Roystonea regia</i> Fruits, in the Male Rat: A Comparison with Finasteride
- Evaluation and treatment of male and female pattern hair loss
- Global photographic assessment of men aged 18 to 60 years with male pattern hair loss receiving finasteride 1 mg or placebo
- Long-term treatment with finasteride 1 mg decreases the likelihood of developing further visible hair loss in men with androgenetic alopecia (male pattern hair loss).
- Fractional non-ablative laser-assisted drug delivery leads to improvement in male and female pattern hair loss
- Topical finasteride for the treatment of male androgenetic alopecia and female pattern hair loss: a review of the current literature
- Male androgenetic alopecia (Part II)
- Psychology’s medicalization of male baldness
- Male Pattern Baldness
- Androgenetic alopecia (male pattern hair loss) in the United States: What treatments should primary care providers recommend?
- Male pattern baldness